前往化源商城

International Journal of Pharmaceutics 2015-06-20

An in-vitro-in-vivo model for the transdermal delivery of cholecalciferol for the purposes of rodent management.

J Davies, A Ingham

文献索引:Int. J. Pharm. 487 , 101-9, (2015)

全文:HTML全文

摘要

The natural selection of anticoagulant resistant rats has resulted in a need for an alternative to anticoagulant rodenticides which differs in both active ingredient and in the method of dosing. Cholecalciferol toxicity to rodents using the dermal route is demonstrated using a variety of penetration enhancing formulations in two in-vitro models and finally in-vivo. A 1 ml dose of 50/50 (v/v) DMSO/ethanol containing 15% (v/v) PEG 200 and 20% (w/v) cholecalciferol was judged as 'sufficiently effective' in line with the European Union's Biocidal Products Regulation (No. 528/2012) during in-vivo studies. This dose was found to cause 100% mortality in a rat population in 64.4h (± 22h).Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

相关化合物

结构式 名称/CAS号 全部文献
乙醇 结构式 乙醇
CAS:64-17-5
L-赖氨酸盐酸盐 结构式 L-赖氨酸盐酸盐
CAS:657-27-2
二甲基亚砜 结构式 二甲基亚砜
CAS:67-68-5
碳酸氢钠 结构式 碳酸氢钠
CAS:144-55-8
2-吡咯烷酮 结构式 2-吡咯烷酮
CAS:616-45-5
油酸 结构式 油酸
CAS:112-80-1
8-辛酰氧基芘-1,3,6-三磺酸三钠盐 结构式 8-辛酰氧基芘-1,3,6-三磺酸三钠盐
CAS:115787-84-3